Suppr超能文献

DNA重排能让我们了解实体血液淋巴肿瘤的哪些信息?

What can DNA rearrangements tell us about solid hematolymphoid neoplasms?

作者信息

Sklar J

机构信息

Department of Pathology, Stanford University, California.

出版信息

Am J Surg Pathol. 1990;14 Suppl 1:16-25.

PMID:2183641
Abstract

Studies of DNA rearrangements in antigen receptor genes and at sites of chromosomal translocations are having an increasing impact on the diagnostic evaluation of lymphoid tissue biopsy specimens. Such rearrangements represent clonal molecular markers that can be very easily detected by Southern blot hybridization or polymerase chain reaction amplification. Detection of these markers can be useful in the diagnosis or subclassification of lymphoid neoplasms, particularly when morphologic or immunophenotypic findings alone are ambiguous. At the same time, application of DNA rearrangement to the evaluation of tissue specimens also has certain shortcomings and limitations, some of which may be overcome by current research methods or advances expected in the near future.

摘要

对抗原受体基因及染色体易位位点处DNA重排的研究,对淋巴组织活检标本的诊断评估影响日益增大。此类重排代表克隆性分子标志物,可通过Southern印迹杂交或聚合酶链反应扩增很容易地检测到。这些标志物的检测在淋巴肿瘤的诊断或亚型分类中可能有用,尤其是当单独的形态学或免疫表型结果不明确时。同时,将DNA重排应用于组织标本评估也有一定的缺点和局限性,其中一些可能会被当前的研究方法或不久的将来预期的进展所克服。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验